Fecal calprotectin concentration in patients with colorectal carcinoma
Diseases of the Colon & Rectum1998Vol. 41(3), pp. 316–321
Citations Over TimeTop 14% of 1998 papers
Jon Kristinsson, Arne Røseth, Magne K. Fagerhol, E. Aadland, H. Schjønsby, Ole P. Børmer, N Raknerud, K. Nygaard
Abstract
Measurement of fecal calprotectin may become a diagnostic tool in detecting colorectal carcinoma. The specificity in relation to colorectal carcinoma has not, however, been completely investigated. Both neoplastic and inflammatory conditions may be associated with elevated values; therefore, it is unlikely that calprotectin can predict specific colonic disorders.
Related Papers
- → Fecal Calprotectin as a Measure of Disease Activity in Childhood Inflammatory Bowel Disease(2001)203 cited
- → Fecal MMP-9(2012)73 cited
- The effect of probiotics on fecal calprotectin in patients with cystic fibrosis.(2015)
- → Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis(2018)18 cited
- The effect of probiotics on fecal calprotectin of patients with cystic fibrosis(2013)